-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Heron Therapeutics, Inc. /De/ quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Heron Therapeutics, Inc. /De/ Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.85M, a 80.6% increase year-over-year.
- Heron Therapeutics, Inc. /De/ Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$28M, a 76.6% increase year-over-year.
- Heron Therapeutics, Inc. /De/ annual Net Income (Loss) Attributable to Parent for 2023 was -$111M, a 39.3% increase from 2022.
- Heron Therapeutics, Inc. /De/ annual Net Income (Loss) Attributable to Parent for 2022 was -$182M, a 17.5% increase from 2021.
- Heron Therapeutics, Inc. /De/ annual Net Income (Loss) Attributable to Parent for 2021 was -$221M, a 2.9% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)